Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1968 Jan;21(1):24–26. doi: 10.1136/jcp.21.1.24

A trial of phosphohexose isomerase as a means of detecting cervical carcinoma

Grainger G Muir 1, Gajute J Valteris 1
PMCID: PMC473656  PMID: 5697331

Abstract

Phosphohexose isomerase activity has been studied in a well women's clinic with an automated method. In this series, in which freeze drying was used, the assay was not a reliable screening technique, as it was found that the method caused considerable loss of enzyme activity.

Full text

PDF
24

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BODANSKY O. Serum phosphohexose isomerase in cancer. I. Method of determination and establishment of range of normal values. Cancer. 1954 Nov;7(6):1191–1199. doi: 10.1002/1097-0142(195411)7:6<1191::aid-cncr2820070611>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  2. BONHAM D. G., GIBBS D. F. A new enzyme test for gynaecological cancer. 6-Phosphogluconate dehydrogenase activity in vaginal fluid. Br Med J. 1962 Sep 29;2(5308):823–824. doi: 10.1136/bmj.2.5308.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HORROCKS J. E., WARD J., KING J. A routine method for the determination of phosphoglucose isomerase activity in body fluid. J Clin Pathol. 1963 May;16:248–251. doi: 10.1136/jcp.16.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Muir G. G., Canti G. 6-phosphogluconate dehydrogenase (6PGD) activity in the vaginal fluid in benign and malignant gynaecological lesions. J Obstet Gynaecol Br Commonw. 1966 Aug;73(4):611–620. doi: 10.1111/j.1471-0528.1966.tb15541.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES